ReviewFrontiers in pharmacology2025
The role of ERK1/2 signaling in diabetes: pathogenic and therapeutic implications.
Hanlin Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it
ReviewFrontiers in pharmacology2025
Hanlin Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.